Sleep NumberNASDAQ: SNBR

Sleep Number (SNBR) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.10 per share a year ago.

Industry sales are expected to wobble for yet another year, but the improvements that SNBR has facilitated on the cost base could see it generate marginal EBITDA growth this year. Looking ahead, even if the topline growth ends up being anemic, EBITDA growth in FY25 and FY26 are poised to come in at double-digit growth levels. The stock is still priced at a discount on a forward EV/EBITDA basis, although that discount has come down from 30% in March to 12.5% currently.

Sleep Number (SNBR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MINNEAPOLIS--(BUSINESS WIRE)--Today, Sleep Number Corporation (Nasdaq: SNBR), the sleep wellness technology leader, unveiled its new Sleep Number® c1 smart bed at only $999 (Queen). The brand's best value, the c1 offers the same signature adjustable firmness on either side and sleep technology features as Sleep Number's higher-end smart beds. For under $1,000, sleepers receive their ideal comfort and support; breathable technology that draws heat away from the body; and personalized digital sle.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

MINNEAPOLIS--(BUSINESS WIRE)--Today, Sleep Number Corporation (Nasdaq: SNBR), a sleep wellness technology leader, announced it will present new research at SLEEP 2024 in Houston. Findings will show results of four studies leveraging smart bed data collected in a real-world, home environment, and the Smart Sleeper Panel, a cohort of more than 468,000 Sleep Number smart bed sleepers who've opted to participate in sleep science research. These studies further demonstrate the research capabilities.

Sleep Number Corporation and the American Cancer Society were awarded the Golden Halo Award for Best Intersectional Initiative in 2024, recognizing their innovative and impactful collaboration. The award, presented by Engage for Good, celebrates initiatives that address multiple causes and communities simultaneously, marking a significant achievement in the corporate world.

Sleep Number (SNBR) passed our 'Fast-Paced Momentum at a Discount' evaluation and may be an appealing option for investors seeking stocks that have experienced significant momentum growth while still being reasonably priced.